THERAPY Hydroxychloroquine in SLE: old drug, new perspectives

被引:43
作者
Doerner, Thomas [1 ,2 ]
机构
[1] Charite, Dept Med Rheumatol & Clin Immunol, D-10098 Berlin, Germany
[2] Deutsch Rheumaforschungszentrum, D-10098 Berlin, Germany
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; DEFICIENCY; INFECTIONS; THROMBOSIS; SURVIVAL; COHORT; RISK;
D O I
10.1038/nrrheum.2009.235
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antimalarial agents have long been used in the treatment of autoimmune diseases, despite uncertainty regarding the exact mechanisms underlying their various effects. growing evidence that these drugs offer protection from major infections could stimulate more research into these mechanisms, with possible implications for therapy.
引用
收藏
页码:10 / 11
页数:3
相关论文
共 10 条
[1]   Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus [J].
Bultink, Irene E. M. ;
Hamann, Doerte ;
Seelen, Marc A. ;
Hart, Margreet H. ;
Dijkmans, Ben A. C. ;
Daha, Mohamed R. ;
Voskuyl, Alexandre E. .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (06)
[2]   Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus [J].
James, J. A. ;
Kim-Howard, X. R. ;
Bruner, B. F. ;
Jonsson, M. K. ;
McClain, M. T. ;
Arbuckle, M. T. ;
Walker, C. ;
Dennis, G. J. ;
Merrill, J. T. ;
Harley, J. B. .
LUPUS, 2007, 16 (06) :401-409
[3]   Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort [J].
Kaiser, R. ;
Cleveland, C. M. ;
Criswell, L. A. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (02) :238-241
[4]   Protective Effect of Hydroxychloroquine on Renal Damage in Patients With Lupus Nephritis: LXV, Data From a Multiethnic US Cohort [J].
Pons-Estel, Guillermo J. ;
Alarcon, Graciela S. ;
Mcgwin, Gerald, Jr. ;
Danila, Maria L. ;
Zhang, Jie ;
Bastian, Holly M. ;
Reveille, John D. ;
Vila, Luis M. .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (06) :830-839
[5]   Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century [J].
Rolain, Jean-Marc ;
Colson, Philippe ;
Raoult, Didier .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (04) :297-308
[6]   Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences [J].
Ruiz-Irastorza, G. ;
Egurbide, M. V. ;
Olivares, N. ;
Martinez-Berriotxoa, A. ;
Aguirre, C. .
RHEUMATOLOGY, 2008, 47 (06) :920-923
[7]   Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus [J].
Ruiz-Irastorza, G. ;
Egurbide, M-V ;
Pijoan, J-I ;
Garmendia, M. ;
Villar, I. ;
Martinez-Berriotxoa, A. ;
Erdozain, J-G ;
Aguirre, C. .
LUPUS, 2006, 15 (09) :577-583
[8]   Previous antimalarial therapy in patients diagnosed with lupus nephiritis:: Influence on outcomes and survival [J].
Siso, A. ;
Ramos-Casals, M. ;
Bove, A. ;
Brito-Zeron, P. ;
Soria, N. ;
Munoz, S. ;
Testi, A. ;
Plaza, J. ;
Sentis, J. ;
Coca, A. .
LUPUS, 2008, 17 (04) :281-288
[9]  
Smitten AL, 2008, J RHEUMATOL, V35, P387
[10]  
Tsakonas E, 1998, LUPUS, V7, P80